NFE2L2 and type 1 diabetes mellitus: Consequently, this current study investigated whether the pharmacological enhancement of the endogenous Nrf2 pathway via the administration of the potent Nrf2 inducer sulforaphane (SFN) could offer protection and minimise the impact of RH on cognitive function in our mouse model of STZ-T1D.